TNF Pharmaceuticals, Inc. Gains 48.15%
Wed, Oct 01, 2025 at 08:28 PM
TNF Pharmaceuticals, Inc. (TNFA:NASDAQ) shot up at $5.2, representing a gain of 48.1%. The stock appeared on our News Catalysts scanner on Wed, Sep 24, 2025 at 10:49 AM in the 'MISCELLANEOUS' category. From Thu, Sep 18, 2025, the stock recorded 22.22% Up Days and 20.00% Green Days
The stock spiked on Wed, Sep 24, 2025 at $8.94 with a volume of 60M+.
About TNF Pharmaceuticals, Inc. (TNFA:NASDAQ)
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms.
Top 10 Gainers:
- Ryvyl Inc. (RVYL:NASDAQ), 71.62%
- Palisade Bio, Inc. (PALI:NASDAQ), 52.38%
- SRAX, Inc. (SRAX:NASDAQ), 50%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- Ambipar Emergency Response (AMBI:NYSEMKT), 44.98%
- Argo Blockchain plc (ARBK:NASDAQ), 39.37%
- Rail Vision Ltd. (RVSN:NASDAQ), 35.34%
- Toro Corp. (TORO:NASDAQ), 34.19%
- Angel Studios Inc. Class A (ANGX:NYSE), 33.56%
- Latch, Inc. (LTCH:NASDAQ), 33.33%